303 related articles for article (PubMed ID: 6992531)
41. New prostacyclin analogues.
Bartmann W; Beck G; Knolle J; Rupp RH
Angew Chem Int Ed Engl; 1980; 19(10):819-20. PubMed ID: 6778259
[No Abstract] [Full Text] [Related]
42. Prostacyclin.
Weksler BB
Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
[No Abstract] [Full Text] [Related]
43. Effect of changes in dietary prostaglandin precursor fatty acids on arterial blood pressure and vascular prostacyclin synthesis.
Düsing R; Scherhag R; Glänzer K; Budde U; Kramer HJ
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():209-15. PubMed ID: 6221595
[No Abstract] [Full Text] [Related]
44. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
Ojima M; Fujita K
Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
[No Abstract] [Full Text] [Related]
45. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
46. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
Moore PK
Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
[No Abstract] [Full Text] [Related]
47. Modified sensitivity of diabetic platelets to prostacyclin.
Bonne C; Romquin N; Regnault F
Bibl Anat; 1979; (18):98-103. PubMed ID: 227357
[No Abstract] [Full Text] [Related]
48. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
Whittle BJ; Moncada S; Mullane K; Vane JR
Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
[TBL] [Abstract][Full Text] [Related]
49. The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.
Weeks JR
Acta Biol Med Ger; 1978; 37(5-6):707-14. PubMed ID: 369253
[TBL] [Abstract][Full Text] [Related]
50. [Effect of exogenous prostaglandins on the cardiovascular system].
Alekseeva NP; Makoeva LD
Sov Med; 1980; (2):96-101. PubMed ID: 6987749
[No Abstract] [Full Text] [Related]
51. Synergic effect of prostacyclin (PGI2) and alpha-blocking-agent on adrenalin-induced human platelet aggregation.
Pogliani E; Fantasia R; Colombi M; Praga C
Thromb Haemost; 1980 Oct; 44(2):106. PubMed ID: 6109380
[No Abstract] [Full Text] [Related]
52. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
[TBL] [Abstract][Full Text] [Related]
53. Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia.
Dadak C; Kefalides A; Sinzinger H
Biol Res Pregnancy Perinatol; 1985; 6(2):65-9. PubMed ID: 3893552
[TBL] [Abstract][Full Text] [Related]
54. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
Aiken JW; Shebuski RJ; Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
Skuballa W; Vorbrüggen H
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():299-305. PubMed ID: 6189381
[No Abstract] [Full Text] [Related]
56. Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin.
Mundy AR; Bewick M; Moncada S; Vane JR
Prostaglandins; 1980 Apr; 19(4):595-603. PubMed ID: 6992233
[TBL] [Abstract][Full Text] [Related]
57. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
Boughton-Smith NK; Vane JR; Whittle BJ
Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
[No Abstract] [Full Text] [Related]
58. Effect of prostacyclin on coronary blood flow and cardiac activity in normotensive and spontaneously hypertensive rats.
Smirnov IE; Mentz PR; Markov CM
Adv Prostaglandin Thromboxane Res; 1980; 7():631-3. PubMed ID: 6989190
[No Abstract] [Full Text] [Related]
59. Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues.
Kovács G; Székely I; Stadler I; Körmöczy P
Acta Physiol Hung; 1984; 64(3-4):225-30. PubMed ID: 6397963
[TBL] [Abstract][Full Text] [Related]
60. [Prostacyclin--inhibitory effect on thrombocyte aggregation on the vascular wall in vivo?].
Sinzinger H; Silberbauer K; Winter M
Vasa; 1978; 7(4):350-9. PubMed ID: 364866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
